The metabolism of salicylazosulphapyridine in ulcerative colitis: I The relationship between metabolites and the response to treatment in inpatients-Reference-Cited by-同舟云学术

The metabolism of salicylazosulphapyridine in ulcerative colitis: I The relationship between metabolites and the response to treatment in inpatients

Published:1973-08-01 Issue:8 Volume:14 Page:631-636
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Das K. M.,Eastwood M. A.,McManus J. P. A.,Sircus W.

Publisher

BMJ

Subject

Gastroenterology

Reference21 articles.

1. Sulphasalazine and salicylazosulphadimidine in ulcerative colitis;Baron, J.H.; Connell, A.M.; Lennard-Jones, J.E.; Jones, F.A.;Lancet,1962

2. From PhD Thesis 'Salicylazosulphapyridine metabolism in clinical practice';Das, K.M.,1973

3. Acetylation polymorphism of sulphapyridine and its constancy in patients with ulcerative colitis and Crohn's disease;Das, K.M.; Eastwood, M.A.,1973

4. Salazopyrin metabolism in ulcerative colitis;Das, K.M.; Eastwood, M.A.; McManus, J.P.A.; Sircus, W.;Gut,1972

5. Controlled trial of sulphasalazine in the treatment of ulcerative colitis;Dick, A.P.; Grayson, M.J.; Carpenter, R.G.; Petrie, A.;Gut,1964

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intestinal Microbiome and Its Impact on Metabolism and Safety of Drugs;Oral Bioavailability and Drug Delivery;2023-10-10

2. Comprehensive Gut Microbiota and Drug Processing;Comprehensive Gut Microbiota;2022

3. Connecting the dots: Targeting the microbiome in drug toxicity;Medicinal Research Reviews;2021-04-15

4. Bioavailability Based on the Gut Microbiota: a New Perspective;Microbiology and Molecular Biology Reviews;2020-05-20

5. Gut microbiota in reductive drug metabolism;Progress in Molecular Biology and Translational Science;2020